Chao Huang
President chez Xi'an Lijun Pharmaceutical Co., Ltd.
Profil
Chao Huang is currently the Director & General Manager at Xi'an Lijun Pharmaceutical Co., Ltd.
since 2011.
He is also a Director at Prime United Industries Ltd.
Mr. Huang previously worked as an Executive Director at SSY Group Ltd.
Mr. Huang holds an MBA from Hong Kong Metropolitan University, which he obtained in 2002.
Postes actifs de Chao Huang
| Sociétés | Poste | Début |
|---|---|---|
Prime United Industries Ltd.
 Prime United Industries Ltd. Financial ConglomeratesFinance Prime United Industries Ltd. operates as an investment holding There is no available country named vg company. | Directeur/Membre du Conseil | 25/03/2010 |
Xi'an Lijun Pharmaceutical Co., Ltd.
 Xi'an Lijun Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Part of Prime United Industries Ltd., Xi'an Lijun Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The company is based in Xian, China. Xi'an Lijun Pharmaceutical Co. was acquired by United Investments Group Ltd. from SSY Group Ltd. on October 31, 2014 for $99.61 million. | President | 09/09/2011 |
Anciens postes connus de Chao Huang
| Sociétés | Poste | Fin |
|---|---|---|
| SSY GROUP LIMITED | Directeur/Membre du Conseil | - |
Formation de Chao Huang
| Hong Kong Metropolitan University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Prime United Industries Ltd.
Prime United Industries Ltd. Financial ConglomeratesFinance Prime United Industries Ltd. operates as an investment holding There is no available country named vg company. | Finance |
Xi'an Lijun Pharmaceutical Co., Ltd.
Xi'an Lijun Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Part of Prime United Industries Ltd., Xi'an Lijun Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The company is based in Xian, China. Xi'an Lijun Pharmaceutical Co. was acquired by United Investments Group Ltd. from SSY Group Ltd. on October 31, 2014 for $99.61 million. | Health Technology |
